Jabre Capital Partners’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-2,900
| Closed | -$410K | – | 80 |
|
|
2018
Q3 | $410K | Buy |
2,900
+600
| +26% | +$84.8K | 0.14% | 83 |
|
|
2018
Q2 | $360K | Sell |
2,300
-100
| -4% | -$15.7K | 0.02% | 121 |
|
|
2018
Q1 | $387K | Buy |
2,400
+500
| +26% | +$80.6K | 0.08% | 122 |
|
|
2017
Q4 | $313K | Sell |
1,900
-4,100
| -68% | -$675K | 0.06% | 76 |
|
|
2017
Q3 | $374K | Buy |
6,000
+2,000
| +50% | +$125K | 0.07% | 81 |
|
|
2017
Q2 | $319K | Sell |
4,000
-18,000
| -82% | -$1.44M | 0.03% | 92 |
|
|
2017
Q1 | $1.56M | Buy |
+22,000
| New | +$1.56M | 0.19% | 77 |
|